2018 Synergy Events – 23rd Congress of the EAHP
- Anticoagulation - from theory to practice (sponsored by an education grant from Bayer)
- Biosimilars in breast cancer – the next challenge (sponsored by an education grant from Amgen)
- Biosimilars in cancer care - the next challenge (financial support was provided by Pfizer Limited as a Medical and Educational Goods and Service)
- The power of automation! (sponsored by an educational grant from Omnicell)
Synergy Satellites Topics - 2018:
1 Antimicrobials – is the pipeline really empty?
2 New options for managing haemophilia – reclaiming one’s life!
3 Printing 3D drugs – soon at the bedside?
4 Traceability of implantable medical devices
5 Anticoagulation - from theory to practice SOLD
6 Compounding facilities – construct or contract?
7 Cholesterol lowering drugs: how low should we go?
8 Managed entry agreements - risk sharing and beyond
9 Biosimilars in cancer care - the next challenge SOLD
10 Falsified medicines directive – 12 months to go!
11 The power of automation! SOLD
12 Biosimilars in auto-immune diseases – to start or to switch IN OPTION
13 Biosimilars in breast cancer – the next challenge SOLD
14 Biosimilars in haemato-oncology - new blood, old questions